Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AFMD

Affimed (AFMD) Stock Price, News & Analysis

Affimed logo

About Affimed Stock (NASDAQ:AFMD)

Advanced Chart

Key Stats

Today's Range
$0.17
$0.24
50-Day Range
$0.09
$0.83
52-Week Range
$0.07
$5.52
Volume
22.99 million shs
Average Volume
4.81 million shs
Market Capitalization
$2.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.62
Consensus Rating
Hold

Company Overview

Affimed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

AFMD MarketRank™: 

Affimed scored higher than 61% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Affimed has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Affimed has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Affimed's stock forecast and price target.
  • Earnings Growth

    Earnings for Affimed are expected to grow in the coming year, from ($4.19) to ($2.05) per share.

  • Price to Book Value per Share Ratio

    Affimed has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Affimed's valuation and earnings.
  • Short Interest

    There is no current short interest data available for AFMD.
  • Dividend Yield

    Affimed does not currently pay a dividend.

  • Dividend Growth

    Affimed does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for AFMD.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Affimed this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for AFMD on MarketBeat in the last 30 days.
  • MarketBeat Follows

    3 people have added Affimed to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Affimed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.80% of the stock of Affimed is held by insiders.

  • Percentage Held by Institutions

    Only 30.82% of the stock of Affimed is held by institutions.

  • Read more about Affimed's insider trading history.
Receive AFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Affimed and its competitors with MarketBeat's FREE daily newsletter.

AFMD Stock News Headlines

Analysts Set Affimed (NASDAQ:AFMD) Target Price at $3.62
OTC:AFMD.Q (Affimed)
This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
Affimed Stock Price, Quotes and Forecasts
See More Headlines

AFMD Stock Analysis - Frequently Asked Questions

Affimed (NASDAQ:AFMD) posted its quarterly earnings results on Wednesday, November, 10th. The biopharmaceutical company reported ($1.40) earnings per share for the quarter, missing analysts' consensus estimates of ($1.30) by $0.10. The biopharmaceutical company had revenue of $10.21 million for the quarter, compared to the consensus estimate of $11.79 million. Affimed had a negative trailing twelve-month return on equity of 193.84% and a negative net margin of 7,836.26%.
Read the conference call transcript
.

Affimed shares reverse split on Monday, March 11th 2024.The 1-10 reverse split was announced on Wednesday, March 6th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 8th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Affimed investors own include Meta Platforms (META), NVIDIA (NVDA), Novavax (NVAX), Tesla (TSLA), Advanced Micro Devices (AMD), Plug Power (PLUG) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
11/10/2021
Today
7/18/2025
Next Earnings (Estimated)
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AFMD
CIK
1608390
Employees
200
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$0.10
Potential Upside/Downside
+1,895.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$114.66 million
Net Margins
-7,836.26%
Pretax Margin
-7,837.50%
Return on Equity
-193.84%
Return on Assets
-107.24%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
1.93
Quick Ratio
1.93

Sales & Book Value

Annual Sales
$877 thousand
Price / Sales
3.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.19 per share
Price / Book
0.04

Miscellaneous

Outstanding Shares
16,100,000
Free Float
15,488,000
Market Cap
$2.92 million
Optionable
Optionable
Beta
2.07

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:AFMD) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners